Key result
Review highlights how novel duck reovirus subverts host defenses alongside emerging diagnostic and vaccine advances.
Why the study?
Novel duck reovirus poses an evolving threat to the duck industry, particularly given the absence of licensed vaccines.
This review highlights current knowledge, research gaps, and priorities for controlling the economically significant Novel duck reovirus in the duck industry.
Answers are grounded in this paper and cite their sources.
Summarizes mechanisms, diagnostics, and vaccine candidates for novel duck reovirus; leaves open priorities for validated control strategies.
Novel duck reovirus (NDRV) is an economically significant pathogen that poses an evolving threat to the duck industry, particularly given the absence of licensed vaccines. This review comprehensively synthesizes recent advances in NDRV research. We elucidate the mechanisms by which NDRV subverts host defenses, primarily through viral protein-mediated suppression of innate antiviral signaling, disruption of intestinal barrier integrity, and systems-level alterations in immune cell dynamics and inflammatory responses. We also critically discuss progress in field-applicable diagnostics and emerging vaccine candidates in the context of the expanding molecular epidemiology of NDRV. Collectively, these insights highlight current knowledge, key research gaps, and priorities for controlling this evolving pathogen.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) conducted a review in Novel duck reovirus (NDRV) infection. This comprehensive review highlights the mechanisms by which Novel duck reovirus subverts host defenses, alongside recent advances in diagnostics and emerging vaccine candidates.
Synapse has enriched 10 related papers. Consider them for comparative context: